Login or Register
Biomedical Learning Institute Taught by the Experts
Thought Leaders
Biomedical Learning Institute
Please Note: The Oncology Learning Center has changed its name to Biomedical Learning Institute
Symposium Co-Chairs


George W. Sledge, Jr., MD
Ballve-Lantero Professor
of Oncology and Pathology
Co-Director, Breast Cancer Program
Indiana University Cancer Center
Co-Chair, Breast Committee,
The Eastern Oncology Cooperative Group
(ECOG)


Dennis J. Slamon, MD, PhD
Chief, Division of Hematology-Oncology
Professor and Executive Vice Chair, Department of Medicine
Director for Clinical Research
Jonsson Comprehensive Cancer Center
Director, Revlon/UCLA Women’s Health Research and Cancer Research Programs
University of California at Los Angeles School of Medicine
Los Angeles, CA

Expert Faculty


Carlos L. Arteaga, MD
Vice Chancellor's
Professor of Breast Cancer Research
Professor of Medicine and
Professor of Cancer Biology
Vanderbilt-Ingram Cancer Center
Nashville, TN


Edi Brogi, MD, PhD
Associate Professor of Clinical Pathology and Laboratory Medicine
Weill Medical College of Cornell University
Associate Attending Pathologist
Memorial Sloan-Kettering Cancer Center
New York, NY


Powel H. Brown, MD, PhD
Professor of Medicine,
Baylor College of Medicine
Associate Director of Cancer Prevention,
Dan L. Duncan Cancer Center
Director of Cancer Prevention and Population Sciences Program,
Dan L. Duncan Cancer Center
Associate Director of Research,
Breast Center
Baylor College of Medicine
Houston, TX


Lisa A. Carey, MD
Medical Director, UNC Breast Center
University of North Carolina
Lineberger Comprehensive Cancer Center
Chapel Hill, NC


David Flockhart, MD, PhD
Director, Division of Endocrinology and
Clinical Pharmacology
Indiana University School of Medicine
Indianapolis, IN


Clifford A. Hudis, MD
Chief, Breast Cancer Medicine Service
Memorial Sloan-Kettering Cancer Center
New York, NY
Co-Chair, Breast Committee,
The Cancer and Leukemia Group B
(CALGB)

Kelly K. Hunt, MD, FACS
Professor of Surgery
Chief, Surgical Breast Section
Department of Surgical Oncology
The University of Texas M. D. Anderson Cancer Center
Houston, TX


V. Craig Jordan, OBE, PhD, DSc
Senior Member Medical Science Division
Vice President and Scientific Director for Medical Science
Alfred G Knudson Jr. Chair in Cancer Research
Fox Chase Cancer Center
Philadelphia, PA


Allan Lipton, MD
Professor of Medicine and Oncology
M. S. Hershey Medical Center of
The Pennsylvania State University
Hershey, PA


Eleftherios P. Mamounas, MD, MPH, FACS
Professor of Surgery,
Northeastern Ohio Universities College of Medicine
Medical Director, Aultman Cancer Center
Canton, Ohio
Chairman, Breast Committee,
National Surgical Adjuvant Breast
and Bowel Project (NSABP)


Hyman Muss , MD
Professor of Medicine
Vermont Cancer Center of
Fletcher Allen Health Care
Burlington, VT


Mark Pegram, MD
Professor of Medicine and Oncology
University of Miami Cancer Center
Miami, FL


Edith A. Perez, MD
Professor of Medicine
Director, Clinical Research,
Mayo Clinic
Jacksonville, FL
Chair, Breast Committee,
The North Central Cancer Treatment Group
(NCCTG)


Charles M. Perou, PhD
Associate Professor
Department of Genetics
University of North Carolina
Chapel Hill, NC


Lori J. Pierce, MD
Vice Provost for Academic and Faculty Affairs Professor,
Department of Radiation Oncology
University of Michigan
Ann Arbor, MI


Malcom C. Pike, PhD

Professor and Acting Chair
Flora L. Thornton Professor
USC Norris Cancer Center
Los Angeles, CA


Michael F. Press, MD, PhD
Holder of Harold E. Lee Chair in Cancer Research
Professor of Pathology
Keck School of Medicine
USC Norris Cancer Center
Los Angeles, CA


Lajos Pusztai, MD, DPhil
Associate Professor of Medicine
Department of Breast Medical Oncology
The University of Texas
M. D. Anderson Cancer Center
Houston, TX


Daniel Silver, MD PhD
Instructor,
Department of Medicine
Harvard Medical School
Instructor, Cancer Biology
Dana-Farber Cancer Institute
Boston, MA


W. Fraser Symmans, MD
Professor of Pathology
The University of Texas
M. D. Anderson Cancer Center
Houston, TX

Katherine Weilbaecher, MD
Associate Professor of Medicine,
Washington University School of Medicine
Division of Molecular Oncology
St. Louis, MO


Jeffrey N. Weitzel, MD
Professor of Medicine,
Medical Oncology
Director of Clinical Cancer Genetics and Cancer Screening and Prevention Program
City of Hope Comprehensive Cancer Center,
Duarte, CA


Eric P. Winer, MD
Director, Breast Oncology Center
Thompson Investigator in Breast Cancer Research
Department of Medical Oncology
Dana-Farber Cancer Institute
Harvard Cancer Center
Boston, MA
Co-Chair, Breast Committee,
The Cancer and Leukemia
Group B (CALGB)

A 1 & 1/2 day, weekend, comprehensive course, taught by the distinguished experts in breast cancer, that is designed to help oncologists and hematologist/oncologists treat their breast cancer patients with a personalized approach, focusing on clinical therapies that can be applied today.

This symposium contains the most up-to-date clinical and scientific information on the personalized treatments of breast cancer.

Earn 13 AMA PRA Category 1 Credits while you are extensively interacting with the distinguished expert faculty through audience response selection of therapies for patient cases, voting on debates on critical topics, and involved in numerous panel discussions, consensus sessions, and asking questions of the faculty.


CO-CHAIRS

George W. Sledge, Jr., MD
Ballve-Lantero Professor of Oncology and Pathology
Co-Director, Breast Cancer Program
Indiana University Cancer Center, Indianapolis, IN
Co-Chair, Breast Committee, The Eastern Oncology Cooperative Group (ECOG)

Dennis J. Slamon, MD, PhD
Chief, Division of Hematology-Oncology
Professor and Executive Vice Chair, Department of Medicine
Director for Clinical Research
Jonsson Comprehensive Cancer Center
Director, Revlon/UCLA Women’s Health Research and Cancer Research Programs
University of California at Los Angeles School of Medicine
Los Angeles, CA



SESSION CHAIRS
and
ORGANIZING COMMITTEE

(and who also are faculty)

Lisa A. Carey, MD
Medical Director, UNC Breast Center
University of North Carolina
Lineberger Comprehensive Cancer Center
Chapel Hill, NC


Clifford A. Hudis, MD
Chief, Breast Cancer Medicine Service
Memorial Sloan-Kettering Cancer Center
New York, NY
Co-Chair, Breast Committee,
The Cancer and Leukemia Group B
(CALGB)


Allan Lipton, MD
Professor of Medicine and Oncology
M. S. Hershey Medical Center of
the Pennsylvania State University
Hershey, PA


Mark Pegram, MD
Professor of Medicine and Oncology
University of Miami Cancer Center
Miami, FL


Edith A. Perez, MD
Professor of Medicine
Director, Clinical Research,
Mayo Clinic
Jacksonville, FL
Chair, Breast Committee,
The North Central Cancer Treatment Group
(NCCTG)


Lori J. Pierce, MD
Vice Provost for Academic and Faculty Affairs Professor,
Department of Radiation Oncology
University of Michigan
AnnArbor, MI


Eric P. Winer, MD
Director, Breast Oncology Center
Thompson Investigator in Breast Cancer Research
Department of Medical Oncology
Dana-Farber Cancer Institute /
Harvard Cancer Center
Boston, MA
Co-Chair, Breast Committee,
The Cancer and Leukemia Group B
(CALGB)

   
Why Attend This Symposium
What's New This Year
Educational Statement of Need
Overview
Disclosure
Target Audience
Learning Objectives
CME Credit Information
Agenda
Faculty
Educational Grants
InterContinental Hotel Information
Registration
   

Disclosure Back to Top
DISCLOSURE STATEMENT AND CONFLICT OF INTEREST POLICY

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Oncology Learning Center (OLC) must demonstrate fair balance, complete independence from any commercial supporters, objectivity, and scientific rigor. All faculty, authors, editors, OLC staff and planning committee members participating in an educational activity who are in control of content or in communication with faculty are required to disclose any relevant financial interest or other relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an OLC educational activity. All disclosures will be made available to all activity participants prior to the conduct of its educational activity. In addition, all conflicts of interest will be resolved and made available to all activity participants prior to the conduct of its educational activity.

 

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Oncology Learning Center does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Oncology Learning Center. Please refer to the official prescribing information for each product for discussion of approved indicated, contraindications, and warnings.

DISCLAIMER
Participants of OLC's educational activities have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development and practices. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Educational Grants

Sincere appreciation is extended to the following companies for their generous commercial support of this educational meeting (Genentech BioOncology, Bristol-Myers Squibb, Novartis, sanofi aventis, Genomic Health, Clarient, Inc., and Agendia):

 

Genentech BioOncology
BMS
Novartis
sanofi aventis
Genomic Health
Clarient, Inc.
Biogen Idec
Agendia
© 2012 Biomedical Learning Institute
1415 Legacy Drive, Suite 250 • Frisco, TX 75034 • Registration Phone: 214.269.2014 • Fax: 214.866.0311
Contact Us
Disclaimer: The material published on the Biomedical Learning Institute(BLI) Web site reflects the opinions and expertise of the authors and/or reviewers of the material, and not the opinions of the BLI, the CME provider, or the commercial supporters providing educational grants. The materials may address uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Before using any therapeutic approaches reviewed in this material, a qualified physician should be consulted. Readers of this content should verify all information and data before treating patients or using any drugs or therapies described in any BLI materials. Click here for our Privacy Policy.